Private Capital Group, LLC Pacira Bio Sciences, Inc. Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 41 shares of PCRX stock, worth $596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41
Previous 41
-0.0%
Holding current value
$596
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PCRX
# of Institutions
301Shares Held
51.5MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$116 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$73.9 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$31.4 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$30 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$27.7 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $666M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...